Enterprise Value
1.222B
Cash
532.8M
Avg Qtr Burn
-24.43M
Short % of Float
16.40%
Insider Ownership
0.47%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EDG-5506 Details Becker Muscular Dystrophy | Phase 2 Data readout | |
Phase 2 Data readout | ||
EDG-5506 Details Rare diseases, Duchenne muscular dystrophy | Phase 2 Data readout | |
EDG-5506 Details Rare diseases, Limb-Girdle Muscular Dystrophy, McArdle disease | Phase 2 Update | |
EDG-5506 Details Duchenne muscular dystrophy, Rare diseases | Phase 2 Update | |
Sevasemten (EDG-5506) Details Becker Muscular Dystrophy | Phase 1b Update | |
EDG-7500 Details Heart disease, Hypertrophic cardiomyopathies | Phase 1 Data readout |